PRECIGEN, INC. - Common Stock, no par value per share (PGEN)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / Common Stock, no par value per share
Shares outstanding
353,523,885
Total 13F shares
61,451,330
Share change
+19,263,720
Total reported value
$65,129,704
Put/Call ratio
170%
Price per share
$1.06
Number of holders
153
Value change
+$19,779,444
Number of buys
85
Number of sells
49

Institutional Holders of PRECIGEN, INC. - Common Stock, no par value per share (PGEN) as of Q1 2023

As of 31 Mar 2023, PRECIGEN, INC. - Common Stock, no par value per share (PGEN) was held by 153 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,451,330 shares. The largest 10 holders included BlackRock Inc., MILLER VALUE PARTNERS, LLC, VANGUARD GROUP INC, IRIDIAN ASSET MANAGEMENT LLC/CT, GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, Patient Capital Management, LLC, and BANK OF AMERICA CORP /DE/. This page lists 154 institutional shareholders reporting positions in this security for the Q1 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.